申请人:Rathod Pradipsinh K.
公开号:US09238653B2
公开(公告)日:2016-01-19
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound:
and a triazolopyrimidine class of compounds that conform to Formula IX:
and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.
寄生性二氢乳酸脱氢酶酶(DHOD)的抑制剂是治疗疟疾的候选治疗药物。这种治疗剂的例子包括化合物:以及符合公式IX的三唑嘧啶类化合物:以及它们的溶剂化物、立体异构体、互变异构体和药学上可接受的盐。